Gottlieb discusses rise of peptides on CNBC's Squawk Box
The former FDA commissioner also addressed the agency's new Rare Disease Framework Initiative and the current measles outbreak.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 19 08:29 ETSource: CNBC
The wire
- 01Former FDA Commissioner Scott Gottlieb appeared on CNBC's Squawk Box to discuss the FDA Rare Disease Framework Initiative, the measles outbreak and the rise of peptides.
- 02Gottlieb's commentary is closely watched by operators tracking how the agency may handle consumer demand for unapproved peptides.
- 03The segment is interview commentary, not agency action; no specific FDA policy on peptides was announced.
From the source
Read at cnbc.comDr. Scott Gottlieb on FDA's Rare Disease Framework, measles outbreak latest and rise of peptides
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the launch of FDA's Rare Disease Framework Initiative, latest developments in the measles outbreak, his thoughts on peptides, and more.
